Stories tagged 'AMP study'
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
Jan. 22, 2018 | By Mary Engel / Fred Hutch News Service
A leader in Peru's battle against HIV/AIDS, Dr. Jorge Sanchez's superpower is research. He is working with the Fred Hutch-based HIV Vaccine Trials Network on a potentially landmark prevention study.
New 'mosaic' HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Dec. 1, 2017 | By Mary Engel / Fred Hutch News Service
The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
Aug. 4, 2017 | By Mary Engel / Fred Hutch News Service
Vic Sorrell knows that the secret behind a successful HIV prevention study is spending the time to establish relationships and earn trust. A pioneer in community engagement, Sorrell works for the Vanderbilt HIV Vaccine Program, a unit of the Fred Hutch-based HIV Vaccine Trials Network.
Empowering ‘millions of women’ against HIV
AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
Oct. 21, 2016 | By Mary Engel / Fred Hutch News Service
The AMP study in sub-Saharan Africa will test whether an antibody infusion protects women against HIV. If it does, the finding will have particular significance for an epidemic that hits women on that continent especially hard and for which they have few prevention options.
Renewed hope for halting HIV through vaccine
At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection
July 19, 2016 | By Mary Engel / Fred Hutch News Service
At the International AIDS Conference in Durban, South Africa, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection.
Seattle's life sciences scene in the spotlight
Xconomy forum highlights research in vaccines, organ transplants, big data, more
May 3, 2016 | By Rachel Tompa / Fred Hutch News Service
It was a dizzying round-up of Seattle’s life sciences research and biotech scene, from designer proteins to the looming threat of the Zika virus. This year’s forum was titled “Life Sciences Disruptors,” though Lash and the other speakers didn’t focus on the technology buzzword theme, but if there was one common thread to the afternoon’s whirlwind tour of Seattle’s public and private life sciences work it was that which is new and unexpected — and a look to the future of healthcare.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Immune booster may awaken body's defenses against skin cancer
Persistent HIV infection works a lot like cancer, study shows
Squelching ovarian cancer: the not-so-silent killer
GIVE NOW &
SAVE LIVES
Story Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
